The objective of this study is to evaluate (1) the effect of a non-restrictive satiating intervention on appetite control, body weight loss and maintenance; and (2) determine whether switching to a non-restrictive satiating intervention following a conventional restrictive intervention can prevent increases in appetite and attenuate body weight regain usually observed after weight loss in men and women living with obesity. This is an 18-month, randomized, controlled, parallel weight loss \[Phase 1 (P1): 6 months\] and maintenance trial \[Phase 2 (P2): 12 months\] with three groups (n=234 men and women): (1) non-restrictive, satiating intervention (P1) followed by a continuation of this intervention (P2); (2) conventional restrictive intervention (-500 kcal/d) (P1) followed by a non-restrictive satiating intervention (P2); (3) control group that follows minimal healthy guidelines (P1) followed by recommended weight maintenance strategies (P2). All groups will be controlled for physical activity and sleep patterns. The non-restrictive satiating intervention will include guidelines and recipes to prepare highly satiating meals that will be low in energy density and glycemic index and high in protein, polyunsaturated fats, vitamins and minerals (e.g. calcium), and certain constituents of spices (e.g. capsaicin). Measurements at baseline (week 0), after P1 and P2 will include the following primary outcomes: appetite control, weight loss and maintenance; and secondary outcomes: body composition, physiological, psycho and neurobehavioural and health-related variables. Follow-ups will be done by a dietitian every 2 weeks during P1 and once a month during P2.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
234
Diet group containing satiating foods
Diet group with a calorie deficit during the first phase followed by a diet containing satiating foods in the second phase
This group will receive minimal healthy guidelines
Department of Physical Education
Québec, Quebec, Canada
RECRUITINGBody weight
Body weight loss (kg) after Phases 1 and 2
Time frame: 6 months
Body composition
Body fat (using dual x-ray absorptiometry)
Time frame: 6 months
Hunger/Satiety
using a visual analogue scale and measured in mm
Time frame: 6 months
Energy intake
measured at an ad libitum meal in kilocalories
Time frame: 6 months
Stress
State-Trait Anxiety Inventory
Time frame: 18 months
Anxiety
Perceived Stress Scales
Time frame: 18 months
Eating Behaviours
Three Factor Eating Behaviour Questionnaire
Time frame: 18 months
Depression Symptoms
Beck Depression Inventory
Time frame: 18 months
Lipids (HDL-cholesterol, LDL-cholesterol, triglycerides, total cholesterol)
measured in mmol/L
Time frame: 18 months
Blood pressure
mmHg
Time frame: 18 months
Diet satisfaction
Diet Satisfaction Questionnaire (scale: strongly disagree to strongly agree)
Time frame: 18 months
neurobehavioural variables
brain anatomy and activity in response to food cues (using fMRI)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.